Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate. Rizzo A. Br J Cancer 2022 Sep 5. pii: 10.1038/s41416-022-01929.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rizzo A. Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate. Br J Cancer 2022 Sep 5. pii: 10.1038/s41416-022-01929.
PMID: 36064585